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Purpose: In the endoscopic treatment of vesicoureteral reflux, the relatively high rate 
of success, the simplicity of the procedure, high patient compliance, and a lack of compli-
cations has led to the increased development of injection materials and techniques. We 
report a method of identifying and maintaining a clear visual field during ureteral and 
bladder submucosal wall injection of a dextranomer/hyaluronic acid copolymer (Deflux, 
Oceana, Therapeutics Inc.) by use of the hydrodistention implantation technique (HIT) 
with the aid of temporary ureteral catheter insertion. 
Materials and Methods: We prospectively reviewed patients with grade IV or V reflux 
who received an endoscopic injection of Deflux. Reflux grade was evaluated before and 
after treatment (3 months) by use of voiding cystourethrograms. Conventional 
sub-trigonal injection (STING) was performed with injection of Deflux underneath the 
bladder mucosa at the 6 o’clock position. HIT was performed either with hydro-
distention or with guidewire insertion. These techniques increase visualization of the 
intramural portion of the distal ureteral wall. Patients with treatment failures were 
offered reinjection up to three times. 
Results: Sixty-three patients completed endoscopic injection and follow-up of 3 months. 
The overall resolution rate for conventional STING was 58%, i.e., 67% for grade IV and 
43% for grade V. The overall resolution rate for HIT was 80%, i.e., 93% for grade IV 
and 66% for grade V. The modified methods showed higher resolution rates for overall 
cure owing to the success in patients with grade IV reflux (p=0.026). Although the suc-
cess of grade V treatment was higher with the modified method, the success rate was 
not statistically significant (p=0.27). 
Conclusions: HIT with the use of either hydrodistention or a guidewire to aid in visual-
ization of the intramural portion of the distal ureter is an effective treatment for 
high-grade vesico-ureteral reflux.
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INTRODUCTION
Vesico-ureteral reflux (VUR) is an abnormal movement of 
urine from the bladder into the ureters or kidneys. VUR af-
fects approximately 1 to 3% of all children [1,2], making it 
the most common pediatric anomaly of the urinary tract [3]. 
Although long-term prophylaxis is generally recomme-
nded as the first choice of therapy for low-grade VUR, 
high-grade VUR has a much lower expectancy of sponta-
neous resolution, with only 52% of cases reported as solved 
at 10 years of follow-up [4,5]. For high-grade VUR, ureter-
oneocystostomy has been the gold standard of therapy, 
with a success rate of over 95%. However, surgery is not free 
of complications, with obstructions occurring in 0.3% to 
9.1% of cases, and grade V VUR has been reported to be re-
sistant to treatment in 20% of cases after reimplantation 
[6].
Since its introduction in the 1980s, endoscopic treatment Korean J Urol 2012;53:194-199
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has become a valid alternative either to antibiotic prophy-
laxis (in low-grade reflux) or to open surgery (in high-grade 
reflux). Across several studies, the method showed a reso-
lution rate of 70 to 90% [7-9]. Although not as effective as 
open ureteral reimplantation, endoscopic correction of 
VUR offers a minimally invasive, outpatient procedure 
with a low risk of complications. Although seemingly sim-
ple, the resolution rate of the procedure has been increased 
with several changes in both materials and techniques 
[10,11].
The general method does not deviate greatly from the ini-
tial sub-trigonal injection (STING) method of Puri [12], 
which was originally designed for injecting polytetrafluo-
roethylene. The success rate of the conventional STING 
method is 88%, 75%, and 52% for grade II, III, and IV VUR, 
respectively [9]. Several attempts have been made to im-
prove the resolution rate of high-grade VUR. The modified 
STING procedure, later known as the hydrodistention im-
plantation technique (HIT), was introduced in 2004 [13]. 
The conventional STING procedure is performed under the 
bladder mucosa, 2 to 3 mm below the affected ureteric or-
ifice, at the 6 o'clock position; in contrast, the modified tech-
nique is performed under the assistance of hydrodistention 
of the orifice, which increases visualization of the injection 
site and allows needle insertion approximately 4 mm in the 
submucosa of the mid to distal ureteral tunnel, at the same 
6 o’clock position [13].
Since 2004, our center has introduced Deflux injections 
for children with high-grade VUR. After originally practic-
ing the conventional STING method, we adopted the HIT 
method. In this study, we present a prospective comparison 
of the treatment efficacy between the HIT method and con-
ventional STING in children with high-grade VUR.
MATERIALS AND METHODS
1. Patients
We prospectively reviewed all cases of endoscopic injection 
of Deflux by either the STING or HIT method for patients 
diagnosed with grade IV or V VUR who underwent treat-
ment at the Korea University Hospital from February 
2004, when our first experience with the use of this treat-
ment occurred, to March 2010. All enrolled patients had 
VUR as determined by voiding cystourethrogram (VCUG) 
and further classification according to the International 
Reflux Study in Children.
We used the standard criteria for intervention, as fol-
lows: breakthrough urinary tract infection during anti-
biotic prophylaxis, progressive renal scarring, noncompli-
ance with medical therapy, nonresolution of VUR, and pa-
rental preference. We excluded from the study patients 
with more complicated urinary anomalies, such as ectopic 
ureter, ureterocele, and neurogenic bladder, as determi-
ned by history or failed surgical reimplantation. All pa-
tients’ guardians were given treatment options based on 
the AUA Pediatric Vesicoureteral Clinical Guidelines, ac-
cording to the patients’ age, severity of reflux, and presence 
of scarring. During the study period, all procedures were 
performed by a single surgeon, with the patient under gen-
eral anesthesia, with the use of injection of a dextrano-
mer/hyaluronic acid copolymer (Deflux, Oceana Thera-
peutics Inc., Edison, NJ, USA). A Wolf 9.5 Fr pediatric cys-
toscope with an offset lens was used in all cases.
2. The conventional STING technique
The technique of endoscopic treatment used in this study 
was similar to that originally described by O’Donnell and 
Puri for polytetrafluoroethylene injection [12]. The 3.7 Fr 
needle was placed under the bladder mucosa 2 to 3 mm be-
low the affected ureteral orifice, at the 6 o’clock position, 
and Deflux was injected inside the lumen until adequate 
mound morphology was attained.
3. The hydrodistention implantation technique 
The modified technique is based on that described by 
Kirsch et al. [13] The bladder is filled to half to three-quar-
ters volume to permit visualization of the ureter and to 
avoid distortion and tension within the submucosal layer 
of the ureter secondary to overdistention. We directed a 
pressured stream of irrigation fluid into the ureter (hydro-
distention) or inserted a guidewire to define the site of in-
jection within the ureteral submucosa. 
After confirmation of the shape and form distorted by hy-
drodistention, a flexible guidewire was additionally placed 
in the ureteral tunnel in case of the need to further enhance 
visualization of the ureter injection site. The guidewire was 
removed when the needle was placed at the injection site, 
so we were able to observe whether the morphology of the 
ureteral orifice was turning into a mound shape and wheth-
er an adequate degree of ureteral coaptation occurred. The 
injection site was approximately 4 mm in the submucosa 
of the mid to distal ureteral tunnel, at the 6 o’clock position 
(Fig. 1). The Deflux was injected into the submucosal intra-
ureteral space, tracking along the entire length of the de-
trusor tunnel.
4. Postoperative management
Follow-up VCUGs were performed between 3 months and 
1 year after the operation. Antibiotic prophylaxis was con-
tinued until resolution of reflux was demonstrated on fol-
low-up imaging. Successful surgical treatment was de-
fined as complete disappearance of VUR. Patients who 
failed were offered reinjection up to three times.
5. Statistical analysis
Results are presented as mean values±SDs or as n values 
(range). According to the STING method, patients were 
divided into two groups and variables were analyzed with 
the Student’s t-test, chi-square test, linear-by-linear asso-
ciation test, and simple correlation analysis by use of SPSS 
ver. 13 (SPSS Inc., Chicago, IL, USA). Differences were con-
sidered statistically significant at p＜0.05.Korean J Urol 2012;53:194-199
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FIG. 1. (A) HIT method modified with 
guidewire-assisted identification of the
injection site. (B) Post-injection mound 
morphology at the ureteral orifice.
TABLE 1. Patient characteristics and vesicoureteral reflux grade
STING method HIT
Conventional 
STING
No. of patients (ureters)
Age (yr)
Gender (male/female)
Laterality (left/right)
Follow-up period (mo)
Grade of reflux IV
Grade of reflux V
45 (59)
  4.16±4.54
25/20
30/29
14.28±8.35
30
29
18 (19)
  5.64±4.51
11/7
11/8
26.32±9.13
12
  7
STING, sub-trigonal injection; HIT, hydrodistention implanta-
tion technique.
TABLE 2. Results of endoscopic treatment for high-grade vesico-
ureteral reflux
STING method HIT
Conventional 
STING
p-value
No. of patients (ureters)
Overall (%)
Grade of reflux IV (%)
    First injection
    Second injection
    Third injection
Grade of reflux V (%)
    First injection
    Second injection
    Third injection
     45 (59)
47/59 (80)
28/30 (93)
26
  1
  1
19/29 (66)
15
  3
  1
     18 (19)
11/19 (58)
  8/12 (67)
7
1
0
    3/7 (43)
2
1
0
0.026
0.270
STING, sub-trigonal injection; HIT, hydrodistention implanta-
tion technique.
RESULTS
A total of 78 ureters in 36 boys and 27 girls were treated, 
including 15 bilateral cases. A total of 63 patients were fol-
lowed up for at least 3 months. The HIT procedure was per-
formed in 45 patients, including 14 bilateral cases (59 ure-
ters; grade IV VUR in 30 and grade V in 29), whereas the 
conventional procedure was performed in 18 patients, in-
cluding 1 bilateral case (19 ureters; grade IV in 12 and 
grade V in 7). The general characteristics of the patients 
(age, gender, and follow-up period) and the vesico-ureteral 
reflux grades are listed and statistically analyzed in Table 
1.
As mentioned above, we offered reinjection up to three 
times in situations in which the first treatment failed. 
Complete resolution occurred in 58% (11/19 ureters) of pa-
tients who received conventional STING, including 67% 
(8/12) of grade IV patients and 43% (3/7) of grade V patients. 
In contrast, the overall cure rate for patients who under-
went HIT was 80% (47/59 ureters), including 93% (28/30) 
of grade IV patients and 66% (19/29) of grade V patients. 
Thus, HIT showed a significantly higher success rate than 
did the conventional method in patients with grade IV VUR 
(p=0.026). In patients with grade V VUR, although the cure 
rate (66%) was higher in group 2 than in group 1 (43%), the 
difference was not statistically significant (p=0.270) (Table 
2).
In patients with grade IV VUR, the first injection was 
successful in 86.7% and 51.7% cases for the modified and 
conventional methods, respectively (p=0.028), whereas in 
patients with grade V VUR, the two methods solved VUR 
at the first attempt in 51.7% and 28.6% cases, respectively. 
The success rates decreased for the second and third 
injections. The number of patients requiring repeated in-
jections was too small for any significant statistical analy-
sis to identify common traits. Although all six patients who 
required repeated injections were bilateral cases, we found 
no significant difference in male-to-female ratio (4:2) or 
age. 
There were no significant complications related to either 
of the two methods (i.e., conventional or modified). One 
child in the HIT group complained of moderate flank pain 
with persistent hydronephrosis several hours after the 
procedure. However, the symptoms resolved within a few 
hours. The hydronephrosis also disappeared at follow-up 
in 1 month.
DISCUSSION
Since its introduction, endoscopic surgery for VUR has Korean J Urol 2012;53:194-199
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gained great popularity owing to its low invasiveness and 
high efficacy. In many centers, single or repeated injections 
for VUR have replaced ureteral reimplantation [14]. Seve-
ral obvious benefits are driving this trend, including a short 
operative time, greater patient satisfaction, lower morbid-
ity, and reduced cost [15]. Although the medical cost may 
vary, the physical and mental burden is significantly de-
creased [16]. 
However, no reported study has approached the cure 
rate of ureteral reimplantation. Older studies from more 
than 10 years ago usually cite a resolution rate of 60 to 75%, 
depending on the material used [7,17]. The success rates 
have improved through the development of new techniques 
and refinement of materials. Recent reports on Deflux in-
jection have consistently shown success rates above 90% 
with either single or repeated injections [8,18,19]. Our 
study showed an overall success rate of 80% for the modi-
fied method, reaching 93% for grade IV VUR.
Several significant factors should be considered in these 
optimistic evaluations. One of the limitations of this treat-
ment is that despite the apparently simple procedure, the 
high resolution rates in all the cited studies sometimes re-
quired multiple, repeated injections; modification and re-
finement of the technique; and an obvious learning curve 
[8,10,18,20]. Our study also showed a significant improve-
ment of the resolution rate with a modification of the meth-
od, from 58% with conventional STING to 80% with the HIT 
method, further applied by insertion of a ureteral catheter. 
Considering that this improvement was brought about 
without a change of materials, we believe that further ap-
plications may allow for even more improvement. The one 
caveat is that we did not suggest the excellence of using a 
guidewire during the procedure. As an application of the 
technique previously described by Kirsh, we ultimately 
used the guidewire as intraluminal hydrodistention when 
we needed to enhance visualization. Whereas submucosal 
injections have been applied previously in other methods, 
the intraluminal portion was the site of injection in this 
method, owing to the effect of hydrodistention.
Similar to other studies, we found cases resistant to 
treatment. In our study, 20% of patients did not improve 
when treated with the modified technique. Other studies 
also found that approximately 10% of patients are resistant 
to treatment [18,19]. Unfortunately, these patients have 
not been clearly characterized. 
In line with previous results, we found a significant de-
crease in the success rate of surgical treatment in children 
suffering from grade V VUR, compared with grade IV, even 
with the modified injection method. In a study of 52 pa-
tients (80 ureters), Lavelle et al. [20] reported a success rate 
of 82% to 73% for grade I to IV and suggested ureteral orifice 
morphology as the primary predictive factor for treatment 
success. Another study by Dave et al. [10] suggested that 
the minimum injection volume of 0.8 ml per ureter was a 
determinant for treatment success, along with the sur-
geon’s experience and low reflux grade. The study pre-
sented various success rates, ranging from 100% for grade 
I to 46.6% for grade V. Higham-Kessler et al. [21] also cate-
gorized mound morphology and suggested that the shifted 
mound shape was associated with recurrence and need for 
reinjection. These results suggested that orifice morphol-
ogy was associated with either primary treatment failure 
or recurrence. Similarly, previous injections with smaller 
particles, such as polytetrafluoroethylene, were primarily 
criticized for the inability of the material to maintain 
mound morphology because of migration [22-24]. Although 
mound morphology may be critical for maintaining treat-
ment effects, the treatment failure groups were heteroge-
neous in these studies. In our group of patients treated with 
the HIT method, the difference in the success rate of 93% 
and 66% for grade IV and V VUR was too large to consider 
the a common denominator for failure across all VUR 
grades. 
In our experience, one of the main difficulties with recre-
ating a proper volcanic-shaped mound by injection in a 
grade V VUR ureter is caused by the decreased thickness 
of the injection site. Other studies have also found a sig-
nificant decrease in the wall thickness of the ureteral wall 
outside the bladder, which is our primary point of injection 
[25]. Studies of refluxing distal ureters have noted a de-
crease in smooth muscle cells, which are replaced with less 
elastic collagen type III fibers in these patients [25,26]. The 
lack of elasticity in the distal ureter, as well as the bladder 
mucosa covering the ureteral orifice, seems to resist re-
shaping by injectable materials. Optimal mound morphol-
ogy is achieved with difficulty, often requiring multiple in-
jection sites and more injection material. 
Other urodynamic factors may also cause treatment 
failures. In other words, we need to consider the bladder 
not only anatomically, but also etiologically. For example, 
some children have difficulty relaxing the sphincter during 
urination and void against the sphincter, straining the 
bladder muscle extensively in the process, thus resulting 
in inefficient voiding. These abnormal voiding patterns are 
referred to as the dysfunctional elimination syndrome 
(DES). The high pressure generated by muscles straining 
against themselves may break down the one-way mecha-
nism of urine flow that normally prevents urine from going 
back up into the kidneys from the bladder. It may also im-
pede the flow of urine from the kidneys into the bladder. 
Thus, Koff et al reported that 66 of 143 (43%) cases with 
primary VUR were accompanied by DES. Moreover, 54 pa-
tients (82%) presented with urinary tract infection, and 
spontaneous resolution was delayed in DES patients. 
Unfortunately, we could not investigate these etiologies, 
because we did not perform videourodynamic study.
For the sake of homogeneity of the treatment population, 
our study focused on high-grade VUR and therefore could 
not identify other uncontrolled factors to suggest a definite 
comparison between the conventional and modified 
methods. One such factor is surgeon experience. As sug-
gested by Dave et al. [10] surgeon experience is a significant 
factor in controlling the outcome of treatment. Our study 
was not performed in a parallel manner between the two Korean J Urol 2012;53:194-199
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methods, because the modified treatment was used more 
recently than the conventional method. However, our over-
all success rates are in line with previous results comparing 
the treatment success rates between the conventional and 
HIT methods [14,27]. Expanding the current patient pool 
and comparing data with previous results could be useful 
for identifying the role of surgeon’s experience in the treat-
ment outcomes.
We consider that the success of the procedure depends 
on coapting the ureteral tunnel, similar to the nonrefluxing 
ureter or the one corrected surgically. To establish this 
goal, the needle is placed in the ureteral tunnel and Deflux 
is injected in the submucosal intraureteral space, tracking 
along the entire length of the detrusor tunnel. It is techni-
cally easier to perform in ureters with higher grade VUR, 
because the needle may be more feasibly placed in an ad-
vantageous position in the ureteral submucosal space.
CONCLUSIONS
The majority of children with VUR undergoing HIT with 
Deflux were cured after 1 treatment. This was our pre-
ferred method of implant injection for the correction of 
high-grade VUR and produced an overall resolution rate 
of 80% (47/59 ureters), reaching 93% (28/30) in patients 
with grade IV VUR. The technique optimizes the ureteral 
coaptation and is easy to perform and is not associated with 
any significant short-term complications. Thus, we consid-
er that the HIT procedure by hydrodistention or ureteral 
catheter-aided visualization is an effective treatment for 
high-grade VUR. 
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